-
Atsushi Nohara
Kanazawa University Health Service Center
-
Hirotoshi Ohmura
Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine
-
Hiroaki Okazaki
Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo
-
Masatsune Ogura
Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute
-
Kazuo Kitagawa
Department of Neurology, Tokyo Women's Medical University
-
Masahiro Koseki
Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine
-
Kayoko Sato
Department of Cardiology, Tokyo Women's Medical University
-
Kazuhisa Tsukamoto
Department of Internal Medicine, Teikyo University School of Medicine
-
Shizuya Yamashita
Department of Community Medicine & Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine Rinku General Medical Center
-
On behalf of the Japan Atherosclerosis Society Working Group on Statement for Appropriate Use of PCSK9 Inhibitors
